Establishment and characterization of leukemic T-cell lines, B-cell lines, and null-cell line: a progress report on surface antigen study of fresh lymphatic leukemias in man. 1977

J Minowada, and T Tsubota, and S Nakazawa, and B I Srivastava, and C C Huang, and M Oshimura, and S Sonta, and T Han, and L F Sinks, and A A Sandberg

Permanent human hematopoietic cell lines representing T-cell, B-cell and non T/non B (null-cell) leukemia have been established. Comparative analyses were made for their phenotype characteristics. A number of characteristics common within the 7 T-cell lines studied or distinct from other leukemia-type lines were described. Usefulness, validity and limitation of these findings are discussed in connection to the attempt at classification of ALL, CLL and blastic phase of CML. The great majority of CLL were SmIg+-B-cell leukemia and a single case of T-cell CLL was documented. Except 10% as T-cell ALL and a single case of B-cell ALL, the majority of ALL were found to be the non T/non B ALL. Nevertheless, little evidence was suggested from the present study in favor for a notion that the T-cell ALL and the non T/non B ALL are two distinct diseases.

UI MeSH Term Description Entries
D007943 Leukemia, Hairy Cell A neoplastic disease of the lymphoreticular cells which is considered to be a rare type of chronic leukemia; it is characterized by an insidious onset, splenomegaly, anemia, granulocytopenia, thrombocytopenia, little or no lymphadenopathy, and the presence of "hairy" or "flagellated" cells in the blood and bone marrow. Hairy Cell Leukemia,Leukemic Reticuloendotheliosis,Reticuloendotheliosis, Leukemic,Hairy Cell Leukemias,Leukemias, Hairy Cell,Leukemic Reticuloendothelioses,Reticuloendothelioses, Leukemic
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011947 Receptors, Antigen, B-Cell IMMUNOGLOBULINS on the surface of B-LYMPHOCYTES. Their MESSENGER RNA contains an EXON with a membrane spanning sequence, producing immunoglobulins in the form of type I transmembrane proteins as opposed to secreted immunoglobulins (ANTIBODIES) which do not contain the membrane spanning segment. Antigen Receptors, B-Cell,B-Cell Antigen Receptor,B-Cell Antigen Receptors,Surface Immunoglobulin,Immunoglobulins, Membrane-Bound,Immunoglobulins, Surface,Membrane Bound Immunoglobulin,Membrane-Bound Immunoglobulins,Receptors, Antigen, B Cell,Surface Immunoglobulins,Antigen Receptor, B-Cell,Antigen Receptors, B Cell,B Cell Antigen Receptor,B Cell Antigen Receptors,Bound Immunoglobulin, Membrane,Immunoglobulin, Membrane Bound,Immunoglobulin, Surface,Immunoglobulins, Membrane Bound,Membrane Bound Immunoglobulins,Receptor, B-Cell Antigen,Receptors, B-Cell Antigen
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003176 Complement C3 A glycoprotein that is central in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C3 can be cleaved into COMPLEMENT C3A and COMPLEMENT C3B, spontaneously at low level or by C3 CONVERTASE at high level. The smaller fragment C3a is an ANAPHYLATOXIN and mediator of local inflammatory process. The larger fragment C3b binds with C3 convertase to form C5 convertase. C3 Complement,C3 Precursor,Complement 3,Complement C3 Precursor,Complement Component 3,Precursor-Complement 3,Pro-C3,Pro-Complement 3,C3 Precursor, Complement,C3, Complement,Complement, C3,Component 3, Complement,Precursor Complement 3,Precursor, C3,Precursor, Complement C3,Pro C3,Pro Complement 3
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000951 Antigens, Neoplasm Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin. Neoplasm Antigens,Tumor Antigen,Tumor Antigens,Antigen, Tumor,Antigens, Tumor
D001402 B-Lymphocytes Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation. B-Cells, Lymphocyte,B-Lymphocyte,Bursa-Dependent Lymphocytes,B Cells, Lymphocyte,B Lymphocyte,B Lymphocytes,B-Cell, Lymphocyte,Bursa Dependent Lymphocytes,Bursa-Dependent Lymphocyte,Lymphocyte B-Cell,Lymphocyte B-Cells,Lymphocyte, Bursa-Dependent,Lymphocytes, Bursa-Dependent
D012397 Rosette Formation The in vitro formation of clusters consisting of a cell (usually a lymphocyte) surrounded by antigenic cells or antigen-bearing particles (usually erythrocytes, which may or may not be coated with antibody or antibody and complement). The rosette-forming cell may be an antibody-forming cell, a memory cell, a T-cell, a cell bearing surface cytophilic antibodies, or a monocyte possessing Fc receptors. Rosette formation can be used to identify specific populations of these cells. Immunocytoadherence,Formation, Rosette,Formations, Rosette,Immunocytoadherences,Rosette Formations

Related Publications

J Minowada, and T Tsubota, and S Nakazawa, and B I Srivastava, and C C Huang, and M Oshimura, and S Sonta, and T Han, and L F Sinks, and A A Sandberg
March 1977, Blood,
J Minowada, and T Tsubota, and S Nakazawa, and B I Srivastava, and C C Huang, and M Oshimura, and S Sonta, and T Han, and L F Sinks, and A A Sandberg
August 1977, Israel journal of medical sciences,
J Minowada, and T Tsubota, and S Nakazawa, and B I Srivastava, and C C Huang, and M Oshimura, and S Sonta, and T Han, and L F Sinks, and A A Sandberg
February 1979, Acta medica Okayama,
J Minowada, and T Tsubota, and S Nakazawa, and B I Srivastava, and C C Huang, and M Oshimura, and S Sonta, and T Han, and L F Sinks, and A A Sandberg
June 1978, Acta medica Okayama,
J Minowada, and T Tsubota, and S Nakazawa, and B I Srivastava, and C C Huang, and M Oshimura, and S Sonta, and T Han, and L F Sinks, and A A Sandberg
December 1979, Gan,
J Minowada, and T Tsubota, and S Nakazawa, and B I Srivastava, and C C Huang, and M Oshimura, and S Sonta, and T Han, and L F Sinks, and A A Sandberg
January 2014, Biological & pharmaceutical bulletin,
J Minowada, and T Tsubota, and S Nakazawa, and B I Srivastava, and C C Huang, and M Oshimura, and S Sonta, and T Han, and L F Sinks, and A A Sandberg
January 1992, In vitro cellular & developmental biology : journal of the Tissue Culture Association,
J Minowada, and T Tsubota, and S Nakazawa, and B I Srivastava, and C C Huang, and M Oshimura, and S Sonta, and T Han, and L F Sinks, and A A Sandberg
May 1990, International journal of cancer,
J Minowada, and T Tsubota, and S Nakazawa, and B I Srivastava, and C C Huang, and M Oshimura, and S Sonta, and T Han, and L F Sinks, and A A Sandberg
December 1980, British journal of experimental pathology,
J Minowada, and T Tsubota, and S Nakazawa, and B I Srivastava, and C C Huang, and M Oshimura, and S Sonta, and T Han, and L F Sinks, and A A Sandberg
September 2008, BMC cell biology,
Copied contents to your clipboard!